
Low Dose Naltrexone Therapy
LDN is a low-cost, off-label prescription with an exceptional safety record — studied in 50+ conditions from autoimmune disease to chronic pain to cancer support.
Your provider will help you find the dose that works best for you.
What is Low Dose Naltrexone?
Naltrexone is an FDA-approved medication originally used at full doses (50mg) to treat opioid and alcohol addiction. At just 1.5–4.5mg — roughly 1/10th of the standard dose — it works through completely different mechanisms, modulating the immune system and calming neuroinflammation.
Pioneered by Dr. Bernard Bihari in the 1980s and studied in hundreds of clinical papers since, LDN has become one of the most promising low-cost off-label treatments in integrative medicine.
Why LDN is gaining attention:
- ~$30–60/month — Typical cost from a compounding pharmacy
- Excellent safety — 30+ years of use, minimal serious side effects
- Immunomodulatory — Regulates immune function — not broadly immunosuppressive
- 50+ conditions — Studied across autoimmune, neurological, pain, and cancer
- One pill nightly — Simple regimen — taken at bedtime
Naltrexone — C20H23NO4 · Molecular weight: 341.4 g/mol
Mechanism of Action
LDN temporarily blocks opioid receptors, triggering a compensatory response that upregulates the body's own endorphins and calms neuroinflammation.

LDN Has Been Studied in Many Conditions
Multiple Sclerosis
An autoimmune disease attacking the central nervous system's myelin sheath.
Crohn's Disease
Chronic inflammatory bowel disease causing GI tract inflammation and ulceration.
Fibromyalgia
A widespread musculoskeletal pain disorder often accompanied by fatigue and cognitive issues.
Hashimoto's Thyroiditis
An autoimmune attack on the thyroid gland causing hypothyroidism.
Long COVID
Persistent symptoms lasting weeks to months after acute COVID-19 infection.
Cancer (Adjunct Support)
LDN as an integrative adjunct to conventional cancer treatment.
Low Dose Naltrexone (LDN) is not FDA-approved for any indication. While naltrexone is an FDA-approved medication at standard doses for opioid and alcohol dependence, the use of naltrexone at low doses is considered off-label prescribing. This website provides educational information about LDN based on published clinical literature and patient experiences. Any discussion or consideration of LDN therapy should occur only in consultation with a qualified healthcare provider who can evaluate your individual medical history, current medications, and clinical circumstances. Pineapple Primary Care does not guarantee any specific outcome from LDN therapy and assumes no liability for decisions made based on this information. Always consult with your healthcare provider before starting, stopping, or modifying any medication.
Ready to Explore LDN?
Book a telehealth consultation with Pineapple Primary Care to discuss whether LDN is right for your situation. Available throughout Florida.
Book a Free Consultation